By 2030, prostate and lung cancers expected to be most common cancers among HIV population

May 7, 2018, American College of Physicians

Despite declines in cancer incidence rates among HIV-infected people, cancer will remain a significant concern as this patient population ages. By 2030, prostate and lung cancers are projected to be the most common cancers among individuals aging with HIV. The findings are published in Annals of Internal Medicine.

Due to their , people living with HIV have a higher risk of some cancers than the general population. The development of modern antiretroviral therapy (ART) has allowed people with HIV to live to older ages and has reduced the risk of certain cancers, such as non-Hodgkin lymphoma and cervical cancer, which were previously prevalent in this population. This trend, along with the aging population, has resulted in a shift in the types of cancers diagnosed in patients with HIV. As such, projecting cancer rates and the expected number of cancers in this high-risk population is necessary to inform public health efforts like cancer screening and prevention.

Researchers from the National Cancer Institute used data from linked HIV and cancer registries to project cancer incidence rates in HIV-infected adults in the U.S. through 2030. They applied those rates to projections of the number of HIV-infected people from the Centers for Disease Control and Prevention (CDC) to estimate the future cancer burden. By 2030, they expect substantial aging of the U.S. HIV , with the proportion of HIV-infected people who are 65+ years old projected to be 21.4 percent (up from 8.5 percent in 2010). While the number of cancer cases diagnosed among adults with HIV is projected to decline, incidence of non-AIDS-defining cancers will remain a concern. Prostate cancer cases are expected to increase over this timeframe, and prostate and lung cancers will each be more common in 2030 than AIDS-defining cancers combined.

According to the researchers, these findings underscore the continuing importance of as a co-morbidity as people with HIV live longer and age. The findings should help to inform the priorities of targeted screening, treatment, and prevention programs.

Explore further: Cancer burden may be changing for people living with HIV

More information: Annals of Internal Medicine (2018). http://annals.org/aim/article/doi/10.7326/M17-2499

Related Stories

Cancer burden may be changing for people living with HIV

April 5, 2017
The total number of cancer cases diagnosed among people living with the human immunodeficiency virus (HIV) is projected to decline in coming years, due mostly to declines in non-Hodgkin lymphoma and Kaposi sarcoma. Certain ...

Cancer burden shifts for people with HIV/AIDS

April 11, 2011
The number of cancers and the types of cancers among people living with AIDS in the U.S. have changed dramatically during the 15-year period from 1991-2005, according to an article published online April 11th in the Journal ...

Large study on cancer in the Métis people of Canada

March 19, 2018
The incidence of all cancers combined was similar for Métis men and significantly higher for Métis women compared to non-Aboriginal men and women, found a study published in CMAJ (Canadian Medical Association Journal)

Second, unrelated malignancies strike 1 in 12 cancer patients

July 11, 2016
(HealthDay)—A new study indicates that 8 percent of patients—or one in 12—already diagnosed with one form of cancer will develop a second unrelated malignancy. The findings were published online July 5 in Cancer.

Aging demographic to push up Canada cancer rate 40%

May 27, 2015
Canada must boost its capacity to treat cancers as new cases among its aging and growing population are set to soar, the Canadian Cancer Society said Wednesday.

CDC: 1.5 million new cancers diagnosed annually

February 25, 2013
(HealthDay)—In 2009, approximately 1.5 million new cases of cancer were diagnosed in the United States, with an annual incidence rate of 459 cases per 100,000 population, according to research published in the Feb. 22 issue ...

Recommended for you

First immunotherapy success for triple-negative breast cancer

October 21, 2018
There is new hope for people with an aggressive type of breast cancer, as an immunotherapy trial shows for the first time that lives can be extended in people with triple-negative breast cancer.

Healthy diets linked to better outcomes in colorectal cancer

October 20, 2018
Colorectal cancer patients who followed healthy diets had a lower risk of death from colorectal cancer and all causes, even those who improved their diets after being diagnosed, according to a new American Cancer Society ...

Why some cancers affect only young women

October 19, 2018
Among several forms of pancreatic cancer, one of them specifically affects women, often young. How is this possible, even though the pancreas is an organ with little exposure to sex hormones? This pancreatic cancer, known ...

Scientists to improve cancer treatment effectiveness

October 19, 2018
Together with researchers from the University of Nantes and the University of Reims Champagne-Ardenne in France, experts from the National Research Nuclear University MEPhI have recently developed a quantum dot-based microarray ...

Mutant cells colonize our tissues over our lifetime

October 18, 2018
By the time we reach middle age, more than half of the oesophagus in healthy people has been taken over by cells carrying mutations in cancer genes, scientists have uncovered. By studying normal oesophagus tissue, scientists ...

Study involving hundreds of patient samples may reveal new treatment options of leukemia

October 17, 2018
After more than five years and 672 patient samples, an OHSU research team has published the largest cancer dataset of its kind for a form of leukemia. The study, "Functional Genomic Landscape of Acute Myeloid Leukemia", published ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.